Interdisciplinary Center of Sleep Medicine, Charité - Universitätsmedizin Berlin, Germany; Department of Medicine, The Fourth People' Hospital of Guangyuan City, China; The Federal State Autonomous Educational Institution of Higher Education I. M. Sechenov, First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia.
Interdisciplinary Center of Sleep Medicine, Charité - Universitätsmedizin Berlin, Germany.
Sleep Med. 2022 Sep;97:64-72. doi: 10.1016/j.sleep.2022.06.001. Epub 2022 Jun 9.
In 2010, a questionnaire-based study on obstructive sleep apnea (OSA) management in Europe identified differences regarding reimbursement, sleep specialist qualification, and titration procedures. Now, 10 years later, a follow-up study was conducted as part of the ESADA (European Sleep Apnea Database) network to explore the development of OSA management over time.
The 2010 questionnaire including questions on sleep diagnostic, reimbursement, treatment, and certification was updated with questions on telemedicine and distributed to European Sleep Centers to reflect European OSA management practice.
26 countries (36 sleep centers) participated, representing 20 ESADA and 6 non-ESADA countries. All 21 countries from the 2010 survey participated. In 2010, OSA diagnostic procedures were performed mainly by specialized physicians (86%), whereas now mainly by certified sleep specialists and specialized physicians (69%). Treatment and titration procedures are currently quite homogenous, with a strong trend towards more Autotitrating Positive Airway Pressure treatment (in hospital 73%, at home 62%). From 2010 to 2020, home sleep apnea testing use increased (76%-89%) and polysomnography as sole diagnostic procedure decreased (24%-12%). Availability of a sleep specialist qualification increased (52%-65%) as well as the number of certified polysomnography scorers (certified physicians: 36%-79%; certified technicians: 20%-62%). Telemedicine, not surveyed in 2010, is now in 2020 used in diagnostics (8%), treatment (50%), and follow-up (73%).
In the past decade, formal qualification of sleep center personnel increased, OSA diagnostic and treatment procedures shifted towards a more automatic approach, and telemedicine became more prominent.
2010 年，一项基于问卷的欧洲阻塞性睡眠呼吸暂停（OSA）管理研究发现，在报销、睡眠专家资格和滴定程序方面存在差异。现在，10 年后，作为 ESADA（欧洲睡眠呼吸暂停数据库）网络的一部分，进行了一项后续研究，以探讨 OSA 管理随时间的发展。
2010 年的问卷包括关于睡眠诊断、报销、治疗和认证的问题，更新了远程医疗问题，并分发给欧洲睡眠中心，以反映欧洲 OSA 管理实践。
26 个国家（36 个睡眠中心）参与，代表 20 个 ESADA 和 6 个非 ESADA 国家。2010 年调查的 21 个国家全部参与。2010 年，OSA 诊断程序主要由专业医生（86%）进行，而现在主要由认证的睡眠专家和专业医生（69%）进行。治疗和滴定程序目前相当统一，更倾向于使用自动滴定正压通气治疗（住院治疗 73%，家庭治疗 62%）。自 2010 年至 2020 年，家庭睡眠呼吸暂停测试的使用增加（76%-89%），而单独使用多导睡眠图作为诊断程序的情况减少（24%-12%）。睡眠专家资格的可用性增加（52%-65%），以及认证多导睡眠图评分员的数量增加（认证医生：36%-79%；认证技术人员：20%-62%）。远程医疗在 2010 年没有调查，现在在 2020 年用于诊断（8%）、治疗（50%）和随访（73%）。
在过去的十年中，睡眠中心人员的正式资格有所提高，OSA 诊断和治疗程序转向更自动的方法，远程医疗变得更加突出。
